Literature DB >> 19420803

Induction of mitosis delay, apoptosis and aneuploidy in human cells by phenyl hydroquinone, an Ames test-negative carcinogen.

Masaru Imai1, Ryo Matsuno, Jun-ichiro Komura, Tetsuya Ono, Kazuo Yamamoto.   

Abstract

Ortho-phenyl phenol and its hepatic derivative, phenyl hydroquinone, do not generate base-substitution-type mutations, but cause bladder cancer in rats and mice. The mechanism of their carcinogenic effect is unknown. We have previously shown that o-phenyl phenol and phenyl hydroquinone induce mitotic arrest and aneuploidy in Saccharomyces cerevisiae. To further delineate the mechanism of action of phenyl hydroquinone, we examined its effect on human cells. Treatment of the colon cancer cell line HCT116 with 0 to 150 microM phenyl hydroquinone caused a concentration-dependent inhibition of growth, accumulation of cells having G2/M DNA content, and an increase in the mitotic index. Moreover, a dose-dependent increase in apoptotic cells was observed. Finally, a high frequency of aneuploid cells was found. On the other hand, no increase in gamma-H2AX foci was observed. The results show that phenyl hydroquinone does induce mitotic arrest, apoptosis and aneuploidy in the absence of DNA damage. Our results may be useful to understand the mechanisms of action of chemical substances that are Ames test-negative carcinogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19420803     DOI: 10.1266/ggs.84.73

Source DB:  PubMed          Journal:  Genes Genet Syst        ISSN: 1341-7568            Impact factor:   1.517


  1 in total

1.  Small molecule-based targeting of TTD-A dimerization to control TFIIH transcriptional activity represents a potential strategy for anticancer therapy.

Authors:  Virginie Gervais; Isabelle Muller; Pierre-Olivier Mari; Amandine Mourcet; Kumar Tekwani Movellan; Pascal Ramos; Julien Marcoux; Valérie Guillet; Sumaira Javaid; Odile Burlet-Schiltz; Georges Czaplicki; Alain Milon; Giuseppina Giglia-Mari
Journal:  J Biol Chem       Date:  2018-08-01       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.